During the past decade, Firestone Institute for Respiratory Health conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Firestone Institute for Respiratory Health" #1 sponsor was "McMaster University" with 11 trials, followed by "St. Joseph's Healthcare Hamilton" with 3 trials sponsored, "Firestone Institute for Respiratory Health" with 2 trials sponsored, "Pharmaxis" with 2 trials sponsored and "Galecto Biotech AB" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Firestone Institute for Respiratory Health" #1 collaborator was "St. Joseph's Healthcare Hamilton" with 5 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "McMaster University" with 2 trials as a collaborator, "West Park Healthcare Centre" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Firestone Institute for Respiratory Health" are "Asthma" (13 trials), "COPD" (3 trials), "Alpha 1-Antitrypsin Deficiency" (1 trials), "Asthma; Eosinophilic" (1 trials) and "Bronchial Diseases" (1 trials). Many other conditions were trialed in "Firestone Institute for Respiratory Health" in a lesser frequency.

Most popular intervention types in "Firestone Institute for Respiratory Health" are "Drug" (13 trials), "Biological" (5 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Hyperpolarized 129Xe MRI" (2 trials), "Reslizumab" (2 trials), "ASM8" (1 trials) and "Benralizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Firestone Institute for Respiratory Health" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Firestone Institute for Respiratory Health". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Firestone Institute for Respiratory Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Firestone Institute for Respiratory Health, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".